These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12230456)

  • 41. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe hypophosphatasia due to mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene.
    Stoll C; Fischbach M; Terzic J; Alembik Y; Vuillemin MO; Mornet E
    Genet Couns; 2002; 13(3):289-95. PubMed ID: 12416636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
    Paul C; Krampl E; Skentou C; Jurkovic D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):481-4. PubMed ID: 11844168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
    Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
    Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuchal translucency in multiple pregnancies.
    Monni G; Zoppi MA; Ibba RM; Putzolu M; Floris M
    Croat Med J; 2000 Sep; 41(3):266-9. PubMed ID: 10962045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
    Souka AP; Krampl E; Bakalis S; Heath V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):9-17. PubMed ID: 11489218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
    Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
    Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites.
    Greenberg CR; Taylor CL; Haworth JC; Seargeant LE; Philipps S; Triggs-Raine B; Chodirker BN
    Genomics; 1993 Jul; 17(1):215-7. PubMed ID: 8406453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuchal translucency and congenital heart defects: heart failure or not?
    Simpson JM; Sharland GK
    Ultrasound Obstet Gynecol; 2000 Jul; 16(1):30-6. PubMed ID: 11084962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuchal translucency in normal fetuses in a Thai population.
    Panburana P; Jaovisidh A; Ajjimakorn S; Tungkajiwangoon P
    J Med Assoc Thai; 2002 Feb; 85(2):245-9. PubMed ID: 12081126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation.
    Van Vugt JM; Tinnemans BW; Van Zalen-Sprock RM
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):407-9. PubMed ID: 9674086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinics in diagnostic imaging (112). Perinatal lethal hypophosphatasia (PLH).
    Kritsaneepaiboon S; Jaruratanasirikul S; Dissaneevate S
    Singapore Med J; 2006 Nov; 47(11):987-92; quiz 993. PubMed ID: 17075671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypophosphatasia.
    Imai S; Sekigawa S; Yamamoto H; Okuyama T; Tsubura Y
    Acta Pathol Jpn; 1982 Sep; 32(5):901-5. PubMed ID: 7136701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.